文献速递中枢神经肿瘤放疗

侧脑室下区接触性胶质母细胞的临床遗传学特征及放疗对神经干细胞微环境的影响

Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma.
PubMed 文献 · Radiother Oncol · 2023-07-07

该研究纳入125例接受手术联合放化疗的胶质母细胞瘤患者,通过82基因二代测序和标准化SVZ/海马勾画分析剂量学因素。SVZ接触性GBM占76%,其无进展生存期低于非接触性GBM(中位8.6 vs 11.5个月,p=0.034),且为独立预后因素,但未关联特定基因特征。在SVZ+GBM中,同侧NSC区高剂量与更好的OS(HR=1.89,p=0.011)和PFS(HR=1.77,p=0.013)相关;而在SVZ-GBM中则与更差的OS(HR=0.27,p=0.013)和PFS(HR=0.37,p=0.035)相关。

要点

  • SVZ+GBM患者无进展生存期低于SVZ-GBM(中位8.6 vs 11.5个月,p=0.034)。
  • SVZ接触不是特定基因谱的关联因素,但为独立预后因素。
  • SVZ+GBM中同侧NSC区高剂量与更好OS(HR=1.89)和PFS(HR=1.77)相关。

核心结论

  • SVZ受累的GBM没有独特的基因特征,但NSC照射在肿瘤接触SVZ的患者中与更好的预后相关。

研究设计与样本

  • 研究纳入125例接受手术联合放化疗的GBM患者,通过82基因靶向二代测序获取基因组谱。
  • 采用标准化方法勾画SVZ和海马中的NSC,分析剂量学因素。
  • SVZ+GBM定义为T1增强图像上GBM伴SVZ受累。
  • 以无进展生存期(PFS)和总生存期(OS)为终点。

主要发现

  • SVZ+GBM患者95例(76%)。
  • SVZ+GBM的PFS低于SVZ-GBM(中位8.6 vs 11.5个月,p=0.034)。
  • SVZ接触与任何特定基因谱无关,但在多因素分析中为独立预后因素。
  • 在SVZ+GBM中,同侧NSC区高剂量组OS(HR=1.89,p=0.011)和PFS(HR=1.77,p=0.013)显著更好。
  • 在SVZ-GBM中,同侧NSC区高剂量与更差OS(HR=0.27,p=0.013)和PFS(HR=0.37,p=0.035)相关,单因素和多因素分析均一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Neural stem cells (NSCs) in the subventricular zone (SVZ) are recognized as the cellular origin of glioblastoma (GBM) and a potential therapeutic target. However, the characteristics of SVZ contacting GBM (SVZ + GBM) and radiotherapeutic strategies for NSCs are still controversial. Here, we investigated the clinicogenetic features of SVZ + GBM and evaluated the dose effect of NSC irradiation depending on SVZ involvement. MATERIALS AND METHODS: We identified 125 patients with GBM treated with surgery followed by chemoradiotherapy. The genomic profiles were obtained by next-generation sequencing targeting 82 genes. NSCs in the SVZ and hippocampus were contoured using standardized methods, and dosimetric factors were analyzed. SVZ + GBM was defined as GBM with SVZ involvement in a T1 contrast-enhanced image. Progression-free survival (PFS) and overall survival (OS) were used as endpoints. RESULTS: The number of patients with SVZ + GBM was 95 (76%). SVZ + GBM showed lower PFS than GBM without SVZ involvement (SVZ-GBM) (median 8.6 vs. 11.5 months, p = 0.034). SVZ contact was not associated with any specific genetic profile but was an independent prognostic factor in multivariate analysis. In SVZ + GBM, patients receiving high doses to the ipsilateral NSC region showed significantly better OS (HR = 1.89, p = 0.011) and PFS (HR = 1.77, p = 0.013). However, in SVZ-GBM, high doses to the ipsilateral NSC region were associated with worse OS (HR = 0.27, p = 0.013) and PFS (HR = 0.37, p = 0.035) in both univariate and multivariate analyses. CONCLUSION: SVZ involvement in GBM was not associated with distinct genetic features. However, irradiation of NSCs was associated with better prognosis in patients with tumors contacting the SVZ.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Kahng JY, Kang BH, Lee ST, et al. Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma. Radiother Oncol. 2023. PMID: 37423479. doi:10.1016/j.radonc.2023.109800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。